Skip navigation
FACT
Focus on Alternative and Complementary Therapies

Healing touch and emotional distress in women undergoing radiation treatment for gynaecological and breast cancer

Cook CAL1, Guerrerio JF2, Slater VE3
1School of Social Work, Saint Louis University, 3550 Lindell Boulevard, St Louis, MO 63103, USA
291 West Glenwood, St Louis, MO 63122, USA
32712 Trelawny Drive, Clarksville, TN 37043, USA

Objective

The aim of this study was to investigate the effect of healing touch (HT) on emotional distress in women undergoing radiation treatment for newly diagnosed gynaecologic or breast cancer.

Materials and methods

A two-arm single-blind RCT was conducted with 78 subjects randomly allocated to either an HT group or a mock treatment (MT) group. Beginning in the first third of their radiation treatment, subjects received six HT or MT sessions without either seeing or talking to their HT or MT providers. Subjects had more than one treatment provider over the course of their six sessions. Emotional distress was measured using the Profile of Mood State (POMS) and the mental health subscales of the SF-36.

Results

Differences in baseline sociodemographic background, medical characteristics, attitudes about HT and emotional distress were not found between the two groups. The HT group made significantly greater within-group improvement on the POMS than the MT group, particularly on the anxiety, anger and confusion subscales. Greater within-group improvements were also found in the HT group on the mental health and emotional role functioning subscales of the SF-36 compared to the MT group.

Conclusion

The significant effect of HT in the emotional distress lends support to its inclusion in treatment protocols for women receiving radiation therapy for breast or gynaecologic cancer.

Acknowledgement

This study was financially supported by Healing Touch of St. Louis and the Barnes-Jewish Hospital Foundation.

Top | Next: Evaluating the effects of the NADA protocol on physical and emotional well-being in women undergoing adjuvant treatment for early breast cancer»
© Pharmaceutical Press 2008
Accessibility | Terms and Conditions